Advertisement

Pharmacy World and Science

, Volume 28, Issue 1, pp 33–38 | Cite as

Identification of Potential Drug-related Problems in the Elderly: The Role of the Community Pharmacist

  • Thijs H. A. M. Vinks
  • Fred H. P. de Koning
  • Ton M. de Lange
  • Toine C. G. Egberts
Article

Abstract

Objective: The high prevalence of multiple drug use combined with age-related changes in pharmacokinetics and pharmacodynamics makes older adults more vulnerable to drug-related problems (DRPs). This pharmacy-based study was performed to identify potential DRPs from prescription records of the elderly and the role of the pharmacist in this process. Method: The study was performed from June 2002 to February 2003 in 16 community pharmacies in the Netherlands. Medication assessment of elderly patients aged 65 and over using six or more drugs concomitantly took place on the date of inclusion. Ten types of potential DRPs, grouped into three categories, were determined. The three groups were patient-related, prescriber-related or drug-related potential DRPs. We looked at the occurrence, nature and determinants of differential potential DRPs. Results: The mean number of prescriptions per patient was 8.7. In total 3.9 potential DRPs per elderly person were identified. The distribution of the potential DRPs over the three categories was: patient related 4.7%, prescriber related 55.7% and drug related 39.6%. Use of NSAIDs (OR 29.9; 95% CI 4.1–219) and digoxin (OR 15.7; 95% CI 4.9–50.5) were associated with the highest risk for potential DRPs. Conclusion: In this vulnerable group of elderly patients potential DRPs frequently occur. Community pharmacists can play an important role in the identification, assessment and prevention of potential DRPs in the elderly. It is useful to investigate which part of potential DRPs can be avoided by the intervention of the community pharmacist in collaboration with the prescriber and the patient.

Keywords

Drug-related problems Polypharmacy Multiple drug use Elderly Medication assessment Community pharmacists The Netherlands 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kaufman DW, Kelly JP, Rosenberg L, Anderson TE and Mitchell AA (2002). Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 287: 337–344CrossRefPubMedGoogle Scholar
  2. 2.
    Veehof LJ, Stewart R, Haaijer-Ruskamp FM and Meyboom-de Jong B (1999). Chronic polypharmacy in one-third of the elderly in family practice. Ned Tijdschr Geneeskd 143: 93–97PubMedGoogle Scholar
  3. 3.
    Masoudi FA and Krumholz HM (2003). Polypharmacy and comorbidity in heart failure. BMJ 327: 513–514CrossRefPubMedGoogle Scholar
  4. 4.
    Murray MD and Callahan CM (2003). Improving medication use for older adults: an integrated research agenda. Ann Intern Med 139: 425–429PubMedGoogle Scholar
  5. 5.
    Veehof L, Stewart R, Haaijer-Ruskamp F and Jong BM (2000). The development of polypharmacy. A longitudinal study. Fam Pract 17: 261–267CrossRefPubMedGoogle Scholar
  6. 6.
    Mangoni AA and Jackson SH (2004). Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 57: 6–14CrossRefPubMedGoogle Scholar
  7. 7.
    Rochon PA and Gurwitz JH (1997). Optimising drug treatment for elderly people: the prescribing cascade. BMJ 315: 1096–1099PubMedGoogle Scholar
  8. 8.
    Lau HS (1998) Drug related problems in the elderly: studies on occurrence and interventions. Thesis, University of UtrechtGoogle Scholar
  9. 9.
    Heerdink ER (1995) Clustering of drug use in the elderly: population based studies into prevalence and outcomes. Thesis, University of UtrechtGoogle Scholar
  10. 10.
    van Dijk KN (2002) Pharmacotherapy in frail elderly: pharmacy data as a tool for improvement. Thesis, University of GroningenGoogle Scholar
  11. 11.
    Bernsten C, Bjorkman I, Caramona M, Crealey G, Frokjaer B and Grundberger E (2001). Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care: a multicentre study in seven European countries. Drugs Aging 18: 63–77CrossRefPubMedGoogle Scholar
  12. 12.
    Veehof LJG (1999) Polypharmacy in the elderly. Thesis, University of GroningenGoogle Scholar
  13. 13.
    Strand LM, Morley PC, Cipolle RJ, Ramsey R and Lamsam GD (1990). Drug-related problems: their structure and function. DICP 24: 1093–1097PubMedGoogle Scholar
  14. 14.
    Schaefer M (2002). Discussing basic principles for a coding system of drug-related problems: the case of PI-Doc. Pharm World Sci 24: 120–127CrossRefPubMedGoogle Scholar
  15. 15.
    van Mil JW, Westerlund LO, Hersberger KE and Schaefer MA (2004). Drug-related problem classification systems. Ann Pharmacother 38: 859–867CrossRefPubMedGoogle Scholar
  16. 16.
    KNMP (2002) Informatorium Medicamentorum. ISBN 90-70605-70-8Google Scholar
  17. 17.
    Health Base Foundation (2002) Comments on medication surveillance Pharmacom and Medicom. GrafiData, Deventer. ISBN 90-74027-17-2Google Scholar
  18. 18.
    Simon SR and Gurwitz JH (2003). Drug therapy in the elderly: improving quality and access. Clin Pharmacol Ther 73: 387–393CrossRefPubMedGoogle Scholar
  19. 19.
    Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J and Beck JC (1991). Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 151: 1825–1832 CrossRefPubMedGoogle Scholar
  20. 20.
    Beers MH (1997). Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 157: 1531–1536CrossRefPubMedGoogle Scholar
  21. 21.
    Zhan C, Sangl J, Bierman AS, Miller MR, Friedman B and Wickizer SW (2001). Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey. JAMA 286: 2823–2829CrossRefPubMedGoogle Scholar
  22. 22.
    Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM and Lewis IK (1992). A method for assessing drug therapy appropriateness. J Clin Epidemiol 45: 1045–1051CrossRefPubMedGoogle Scholar
  23. 23.
    Kassam R, Martin LG and Farris KB (2003). Reliability of a modified medication appropriateness index in community pharmacies. Ann Pharmacother 37: 40–46CrossRefPubMedGoogle Scholar
  24. 24.
    Knight EL and Avorn J (2001). Quality indicators for appropriate medication use in vulnerable elders. Ann Intern Med 135: 703–710PubMedGoogle Scholar
  25. 25.
    Sorensen L, Grobler MP and Roberts MS (2003). Development of a quality use of medicines coding system to rate clinical pharmacists’ medication review recommendations. Pharm World Sci 25: 212–217CrossRefPubMedGoogle Scholar
  26. 26.
    Meyboom RH, Lindquist M and Egberts AC (2000). An ABC of drug-related problems. Drug Saf 22: 415–423CrossRefPubMedGoogle Scholar
  27. 27.
    van Dijk KN, de Vries CS, van den Berg PB, Brouwers JRBJ and de Jong-van den Berg LTW (2001). Occurrence of potential drug-drug interaction in nursing home residents. Int J Pharm Pract 9: 45–52Google Scholar
  28. 28.
    Heerdink ER, Leufkens HG, Herings RM, Ottervanger JP, Stricker BH and Bakker A (1998). NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Arch Intern Med 158: 1108–1112CrossRefPubMedGoogle Scholar
  29. 29.
    Hanlon JT, Schmader KE, Boult C, Artz MB, Gross CR and Fillenbaum GG (2002). Use of inappropriate prescription drugs by older people. J Am Geriatr Soc 50: 26–34CrossRefPubMedGoogle Scholar
  30. 30.
    Hanlon JT, Weinberger M, Samsa GP, Schmader KE, Uttech KM and Lewis IK (1996). A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 100: 428–437CrossRefPubMedGoogle Scholar
  31. 31.
    Zermansky AG, Petty DR, Raynor DK, Freemantle N, Vail A and Lowe CJ (2001). Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ 323: 1340–1343CrossRefPubMedGoogle Scholar
  32. 32.
    Pullar T, Birtwell AJ, Wiles PG, Hay A and Feely MP (1988). Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily. Clin Pharmacol Ther 44: 540–545PubMedCrossRefGoogle Scholar
  33. 33.
    Salzman C (1995) Medication compliance in the elderly. J Clin Psychiatry 56(Suppl 1):18–22; discussion 23Google Scholar
  34. 34.
    Rollason V and Vogt N (2003). Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist. Drugs Aging 20: 817–832CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, B.V. 2006

Authors and Affiliations

  • Thijs H. A. M. Vinks
    • 1
    • 2
    • 4
  • Fred H. P. de Koning
    • 1
    • 3
    • 4
  • Ton M. de Lange
    • 5
  • Toine C. G. Egberts
    • 1
    • 4
  1. 1.Department of Pharmacoepidemiology and PharmacotherapyUtrecht Institute for Pharmaceutical Sciences (UIPS)UtrechtThe Netherlands
  2. 2.Venloon PharmacyLoon op ZandThe Netherlands
  3. 3.Kring Pharmaciess-HertogenboschThe Netherlands
  4. 4.Brabant Institute for Pharmaceutical Research and Development (BIRD)TilburgThe Netherlands
  5. 5.Ton de Lange Management b.vBloemendaalThe Netherlands

Personalised recommendations